miR-203a regulates proliferation, migration, and apoptosis by targeting glycogen synthase kinase-3β in human renal cell carcinoma
- 15 August 2014
- journal article
- research article
- Published by Springer Nature in Tumor Biology
- Vol. 35 (11) , 11443-11453
Abstract
MicroRNAs play a crucial role in cancer progression and metastasis. miR-203a has been identified as a tumor suppressor in various cancers. However, its functions in renal cell carcinoma have not been illustrated. In this study, we detected the miR-203a expression in renal cell carcinoma and evaluated its association with clinical features. Overexpression of miR-203a was found in renal cell carcinoma tissues and renal cell carcinoma cells. High miR-203a expression is correlated with tumor stage and short overall survival time. Bioinformatics and luciferase assay confirmed that glycogen synthase kinase-3β was a target gene of miR-203a. Silencing of miR-203a could inhibit cell proliferation and migration, arrest them in G1 phase, and promote apoptosis in vitro. miR-203a promotes the progression of renal cell carcinoma and predicts a poor prognosis.Keywords
This publication has 33 references indexed in Scilit:
- Glycogen synthase kinase 3 beta inhibits microRNA-183-96-182 cluster via the β-Catenin/TCF/LEF-1 pathway in gastric cancer cellsNucleic Acids Research, 2013
- Glycogen synthase kinase 3 promotes p53 mRNA translation via phosphorylation of RNPC1Genes & Development, 2013
- miR-203 Inhibits Cell Proliferation and Migration of Lung Cancer Cells by Targeting PKCαPLOS ONE, 2013
- GSK3β controls epithelial–mesenchymal transition and tumor metastasis by CHIP-mediated degradation of SlugOncogene, 2013
- MiR203 mediates subversion of stem cell properties during mammary epithelial differentiation via repression of ΔNP63α and promotes mesenchymal-to-epithelial transitionCell Death & Disease, 2013
- MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cellsJournal of Experimental & Clinical Cancer Research, 2012
- miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expressionCancer Letters, 2011
- MicroRNA control of signal transductionNature Reviews Molecular Cell Biology, 2010
- Renal-Cell CarcinomaNew England Journal of Medicine, 2005
- The renaissance of GSK3Nature Reviews Molecular Cell Biology, 2001